Soo Hyun Kim

1 ta ish

Kai Biotech (South Korea)

1. The combination of calreticulin-targeting L-ASNase and anti-PD-L1 antibody modulates the tumor immune microenvironment to synergistically enhance the antitumor efficacy of radiotherapy

   Ying Zhang, V. Akhil, Ho Seong Seo +8

   MaqolaOAOchiq kirishCancer Research and TreatmentsTheranostics20240 iqtibos

   ABIABI:AkademIndex/2024.article.000480